| First Author | Xu (???) Y | Year | 2021 |
| Journal | Arterioscler Thromb Vasc Biol | Volume | 41 |
| Issue | 6 | Pages | e284-e298 |
| PubMed ID | 33441025 | Mgi Jnum | J:362652 |
| Mgi Id | MGI:8158089 | Doi | 10.1161/ATVBAHA.120.314156 |
| Citation | Xu Y, et al. (2021) E17241 as a Novel ABCA1 (ATP-Binding Cassette Transporter A1) Upregulator Ameliorates Atherosclerosis in Mice. Arterioscler Thromb Vasc Biol 41(6):e284-e298 |
| abstractText | Reverse cholesterol transport, removing excess cholesterol from peripheral tissues, is an important therapeutic target for atherosclerosis treatment. In this study, we propose a new small molecule, E17241, that may be used to treat atherosclerosis by promoting reverse cholesterol transport via ABCA1 (ATP-binding cassette transporter A1) upregulation. |
